155 related articles for article (PubMed ID: 18993078)
21. IRAK-4 inhibitors. Part 1: a series of amides.
Buckley GM; Gowers L; Higueruelo AP; Jenkins K; Mack SR; Morgan T; Parry DM; Pitt WR; Rausch O; Richard MD; Sabin V; Fraser JL
Bioorg Med Chem Lett; 2008 Jun; 18(11):3211-4. PubMed ID: 18474425
[TBL] [Abstract][Full Text] [Related]
22. New potent and selective polyfluoroalkyl ketone inhibitors of GVIA calcium-independent phospholipase A2.
Magrioti V; Nikolaou A; Smyrniotou A; Shah I; Constantinou-Kokotou V; Dennis EA; Kokotos G
Bioorg Med Chem; 2013 Sep; 21(18):5823-9. PubMed ID: 23916152
[TBL] [Abstract][Full Text] [Related]
23. Phospholipase A2 biochemistry.
Burke JE; Dennis EA
Cardiovasc Drugs Ther; 2009 Feb; 23(1):49-59. PubMed ID: 18931897
[TBL] [Abstract][Full Text] [Related]
24. Design, synthesis, and evaluation of new type of L-amino acids containing pyridine moiety as nitric oxide synthase inhibitor.
Ijuin R; Umezawa N; Higuchi T
Bioorg Med Chem; 2006 May; 14(10):3563-70. PubMed ID: 16466923
[TBL] [Abstract][Full Text] [Related]
25. 1-Indol-1-yl-propan-2-ones and related heterocyclic compounds as dual inhibitors of cytosolic phospholipase A(2)alpha and fatty acid amide hydrolase.
Forster L; Ludwig J; Kaptur M; Bovens S; Elfringhoff AS; Holtfrerich A; Lehr M
Bioorg Med Chem; 2010 Jan; 18(2):945-52. PubMed ID: 20005725
[TBL] [Abstract][Full Text] [Related]
26. Synthesis of N-(trifluoromethyl-2-pyridinyl)arenesulfonamides as an inhibitor of secretory phospholipase A₂.
Nakayama H; Morita Y; Kimura H; Ishihara K; Akiba S; Uenishi J
Chem Pharm Bull (Tokyo); 2011; 59(6):783-6. PubMed ID: 21628920
[TBL] [Abstract][Full Text] [Related]
27. 1-(2-Carboxyindol-5-yloxy)propan-2-ones as inhibitors of human cytosolic phospholipase A2alpha: synthesis, biological activity, metabolic stability, and solubility.
Fritsche A; Elfringhoff AS; Fabian J; Lehr M
Bioorg Med Chem; 2008 Apr; 16(7):3489-500. PubMed ID: 18321717
[TBL] [Abstract][Full Text] [Related]
28. Catalytic residues of group VIB calcium-independent phospholipase A2 (iPLA2gamma).
Tanaka H; Minakami R; Kanaya H; Sumimoto H
Biochem Biophys Res Commun; 2004 Aug; 320(4):1284-90. PubMed ID: 15249229
[TBL] [Abstract][Full Text] [Related]
29. A series of novel, potent, and selective histone deacetylase inhibitors.
Jones P; Altamura S; Chakravarty PK; Cecchetti O; De Francesco R; Gallinari P; Ingenito R; Meinke PT; Petrocchi A; Rowley M; Scarpelli R; Serafini S; Steinkühler C
Bioorg Med Chem Lett; 2006 Dec; 16(23):5948-52. PubMed ID: 16987657
[TBL] [Abstract][Full Text] [Related]
30. Design of new potent and selective secretory phospholipase A2 inhibitors. Part 5: synthesis and biological activity of 1-alkyl-4-[4,5-dihydro-1,2,4-[4H]-oxadiazol-5-one-3-ylmethylbenz-4'-yl(oyl)] piperazines.
Boukli L; Touaibia M; Meddad-Belhabich N; Djimdé A; Park CH; Kim JJ; Yoon JH; Lamouri A; Heymans F
Bioorg Med Chem; 2008 Feb; 16(3):1242-53. PubMed ID: 17993277
[TBL] [Abstract][Full Text] [Related]
31. Development of Potent and Selective Inhibitors for Group VIA Calcium-Independent Phospholipase A2 Guided by Molecular Dynamics and Structure-Activity Relationships.
Mouchlis VD; Limnios D; Kokotou MG; Barbayianni E; Kokotos G; McCammon JA; Dennis EA
J Med Chem; 2016 May; 59(9):4403-14. PubMed ID: 27087127
[TBL] [Abstract][Full Text] [Related]
32. Synthesis of benzoyl phenyl benzoates as effective inhibitors for phospholipase A2 and hyaluronidase enzymes.
Khanum SA; Murari SK; Vishwanth BS; Shashikanth S
Bioorg Med Chem Lett; 2005 Sep; 15(18):4100-4. PubMed ID: 15993585
[TBL] [Abstract][Full Text] [Related]
33. Group V secretory phospholipase A2 plays a pathogenic role in myocardial ischaemia-reperfusion injury.
Yano T; Fujioka D; Saito Y; Kobayashi T; Nakamura T; Obata JE; Kawabata K; Watanabe K; Watanabe Y; Mishina H; Tamaru S; Kugiyama K
Cardiovasc Res; 2011 May; 90(2):335-43. PubMed ID: 21169294
[TBL] [Abstract][Full Text] [Related]
34. (E)-Phenyl- and -heteroaryl-substituted O-benzoyl-(or acyl)oximes as lipoprotein-associated phospholipase A2 inhibitors.
Jeong TS; Kim MJ; Yu H; Kim KS; Choi JK; Kim SS; Lee WS
Bioorg Med Chem Lett; 2005 Mar; 15(5):1525-7. PubMed ID: 15713421
[TBL] [Abstract][Full Text] [Related]
35. Inhibition of secretory phospholipase A2. 2-Synthesis and structure-activity relationship studies of 4,5-dihydro-3-(4-tetradecyloxybenzyl)-1,2,4-4H-oxadiazol-5-one (PMS1062) derivatives specific for group II enzyme.
Dong CZ; Ahamada-Himidi A; Plocki S; Aoun D; Touaibia M; Meddad-Bel Habich N; Huet J; Redeuilh C; Ombetta JE; Godfroid JJ; Massicot F; Heymans F
Bioorg Med Chem; 2005 Mar; 13(6):1989-2007. PubMed ID: 15727853
[TBL] [Abstract][Full Text] [Related]
36. Peptide deformylase inhibitors with retro-amide scaffold: synthesis and structure-activity relationships.
Lee SK; Choi KH; Lee SJ; Suh SW; Kim BM; Lee BJ
Bioorg Med Chem Lett; 2010 Aug; 20(15):4317-9. PubMed ID: 20615695
[TBL] [Abstract][Full Text] [Related]
37. Quinoline-4-methyl esters as human nonpancreatic secretory phospholipase A₂ inhibitors.
Wu Y; Chen Z; Liu Y; Yu L; Zhou L; Yang S; Lai L
Bioorg Med Chem; 2011 Jun; 19(11):3361-6. PubMed ID: 21555224
[TBL] [Abstract][Full Text] [Related]
38. A potent and selective inhibitor of group IIa secretory phospholipase A2 protects rats from TNBS-induced colitis.
Woodruff TM; Arumugam TV; Shiels IA; Newman ML; Ross PA; Reid RC; Fairlie DP; Taylor SM
Int Immunopharmacol; 2005 May; 5(5):883-92. PubMed ID: 15778124
[TBL] [Abstract][Full Text] [Related]
39. Alpha-lipoic acid: an inhibitor of secretory phospholipase A2 with anti-inflammatory activity.
Jameel NM; Shekhar MA; Vishwanath BS
Life Sci; 2006 Dec; 80(2):146-53. PubMed ID: 17011589
[TBL] [Abstract][Full Text] [Related]
40. Inhibition of the complete set of mammalian secreted phospholipases A(2) by indole analogues: a structure-guided study.
Smart BP; Pan YH; Weeks AK; Bollinger JG; Bahnson BJ; Gelb MH
Bioorg Med Chem; 2004 Apr; 12(7):1737-49. PubMed ID: 15028265
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
